Your browser doesn't support javascript.
loading
Comprehensive Analysis of the Immune Infiltrates of Pyroptosis in Kidney Renal Clear Cell Carcinoma.
Sun, Zhuolun; Jing, Changying; Guo, Xudong; Zhang, Mingxiao; Kong, Feng; Wang, Zhenqing; Jiang, Shaobo; Wang, Hanbo.
Afiliación
  • Sun Z; Department of Urology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Jing C; School of Medicine, Technical University of Munich, Munich, Germany.
  • Guo X; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Zhang M; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Kong F; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Wang Z; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Jiang S; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Wang H; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Front Oncol ; 11: 716854, 2021.
Article en En | MEDLINE | ID: mdl-34568046
ABSTRACT
Kidney renal clear cell carcinoma (KIRC) has long been identified as a highly immune-infiltrated tumor. However, the underlying role of pyroptosis in the tumor microenvironment (TME) of KIRC remains poorly described. Herein, we systematically analyzed the prognostic value, role in the TME, response to ICIs, and drug sensitivity of pyroptosis-related genes (PRGs) in KIRC patients based on The Cancer Genome Atlas (TCGA) database. Cluster 2, by consensus clustering for 24 PRGs, presented a poor prognosis, likely because malignancy-related hallmarks were remarkably enriched. Additionally, we constructed a prognostic prediction model that discriminated well between high- and low-risk patients and was further confirmed in external E-MTAB-1980 cohort and HSP cohort. By further analyzing the TME based on the risk model, higher immune cell infiltration and lower tumor purity were found in the high-risk group, which presented a poor prognosis. Patients with high risk scores also exhibited higher ICI expression, indicating that these patients may be more prone to profit from ICIs. The sensitivity to anticancer drugs that correlated with model-related genes was also identified. Collectively, the pyroptosis-related prognosis risk model may improve prognostic information and provide directions for current research investigations on immunotherapeutic strategies for KIRC patients.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China